November 17, 2026 · Yoon Hang Kim MD
Why Supplement Interactions Matter With Apixaban
Apixaban is metabolized primarily by CYP3A4 and transported by P-glycoprotein (P-gp). A supplement can interact with apixaban through three mechanisms:
- CYP3A4 inhibition — slows apixaban clearance → higher drug levels → increased bleeding risk
- CYP3A4 induction — speeds apixaban clearance → lower drug levels → reduced protection against clots
- Additive antiplatelet/anticoagulant effect — the supplement itself inhibits platelet aggregation or clotting, compounding apixaban's blood-thinning action
Unlike warfarin, apixaban does not work through the vitamin K pathway, so dietary vitamin K intake does not affect its efficacy. "No known interaction" means no interaction has been documented — not that one has been proven absent.
GREEN — No Known Interaction at Standard Doses
These supplements have no documented pharmacokinetic or pharmacodynamic interaction with apixaban. Standard doses are assumed. Always disclose to prescriber/pharmacist.
Supplement | Status | Notes |
|---|
Vitamin D3 | No interaction | No CYP3A4 or P-gp involvement. Kidney disease or hypercalcemia requires separate caution. |
Vitamin C (ascorbic acid) | No interaction | No documented interaction with apixaban at normal doses. |
Vitamin B12 (cobalamin) | No interaction | Safe at standard supplementation doses. |
Folate / Folic acid | No interaction | No CYP3A4, P-gp, or antiplatelet involvement. |
Other B vitamins (B1, B2, B3, B5, B6, biotin) | No interaction | No documented interactions with apixaban. |
Vitamin K | No interaction | Unlike warfarin, apixaban is not a vitamin K antagonist. No dietary restriction needed. |
Zinc | No interaction | No effect on bleeding risk or apixaban metabolism. |
Selenium | No interaction | No clinically significant interaction documented. |
Iron | No interaction | Timing with other meds still matters for absorption. |
Calcium | No interaction | Separate from thyroid hormones and some antibiotics for absorption. |
Magnesium (glycinate, citrate, oxide) | Minor / No clinical concern | Not shown to increase bleeding risk at supplement doses. Kidney impairment requires separate caution. |
Standard multivitamin (no herbal blends) | No interaction | Choose products without added botanicals or high-dose vitamin E. |
CoQ10 (ubiquinone) | No interaction | Safe to combine. No clinically significant impact on anticoagulant drugs. |
Collagen peptides | No interaction | Amino acid profile has no anticoagulant activity. |
Glutathione | No interaction | No evidence of effect on apixaban's action or effectiveness. |
Probiotics | No interaction | Start at low doses; avoid very high CFU or spore-forming products. |
Vitamin A (standard doses) | No interaction | No CYP3A4 or antiplatelet involvement at standard doses. |
Acetaminophen (Tylenol) | No interaction | First-line OTC pain option on Eliquis. |
YELLOW — Use With Caution / Discuss With Prescriber
These supplements have theoretical or minor documented interactions with apixaban. Not automatically prohibited, but require an informed conversation with prescriber or pharmacist, particularly at higher doses.
Supplement | Risk Mechanism | Rating | Clinical Notes |
|---|
Fish oil / Omega-3 (EPA, DHA) | Additive antiplatelet | Minor | Generally safe at normal doses. Theoretical risk at very high doses. |
Melatonin | CYP3A4 inhibition + antiplatelet | Minor–Moderate | Use lowest effective dose; inform prescriber. |
Ashwagandha | CYP3A4 induction (in vitro) | Minor | No clinically significant effect on coagulation in humans at typical doses. |
NAC (N-acetyl cysteine) | Antiplatelet effect | Moderate | Findings based on IV; unclear if oral produces same effect. |
Quercetin | CYP3A4 + P-gp inhibition | Moderate | May increase apixaban bioavailability. Use cautiously. |
Echinacea | CYP3A4 modulation | Moderate | Induces hepatic but inhibits intestinal CYP3A4. Exercise caution. |
Green tea extract (concentrated) | CYP3A4 inhibition + antiplatelet | Moderate | Moderate tea drinking likely fine; concentrated extract needs caution. |
Garlic supplements (concentrated) | CYP3A4 modulation + antiplatelet | Moderate | Culinary garlic not a concern; concentrated pills warrant review. |
Ginger extract (concentrated) | Additive antiplatelet | Moderate | Culinary ginger not a concern at normal amounts. |
Panax ginseng | CYP3A4 modulation + antiplatelet | Moderate | Human studies have not confirmed antiplatelet effect. |
Vitamin E (high-dose, >400 IU) | Additive bleeding risk | Moderate | Standard-dose in multivitamin is fine. High-dose is the concern. |
Tocotrienols | Antiplatelet (theoretical) | Minor | 400–800 mg daily with aspirin for 1 year showed no bleeding. |
Resveratrol | CYP3A4 inhibition + antiplatelet | Moderate | No controlled human interaction studies with apixaban. |
Motherwort | Antiplatelet (IV only) | Minor | Likely safe orally. |
Goji berry | CYP3A4 inhibition (in vitro) | Minor | Not reported in humans. |
RED — Avoid or Strongly Discourage With Apixaban
These supplements have major documented or strongly probable interactions. Avoid unless a prescriber has specifically reviewed and approved the combination with active monitoring.
Supplement | Risk Mechanism | Rating | Why It Matters |
|---|
St. John's wort | Strong CYP3A4 + P-gp induction | Major | Most dangerous herbal interaction. Significantly reduces apixaban levels. Do not combine. |
Turmeric / Curcumin (supplement) | CYP3A4 inhibition + antiplatelet | Major | Inhibits CYP3A4; has own antiplatelet effects. Culinary amounts differ from capsules. |
Ginkgo biloba | Antiplatelet + CYP3A4 | Major | Antiplatelet properties; may increase bleeding. |
Dong quai | Additive anticoagulant | Major | Known anticoagulant properties. On Drugs.com major interaction list. |
Goldenseal | CYP3A4 + P-gp inhibition | Major | Inhibits CYP3A4 and increases serum levels of substrates. |
Berberine (standalone) | CYP3A4 + P-gp + antiplatelet | Major | Inhibits CYP3A4, P-gp, and platelet aggregation. |
White willow bark | Antiplatelet (aspirin-like) | Major | Contains salicin. Additive bleeding risk with apixaban. |
Feverfew | Antiplatelet | Moderate–Major | Inhibits platelet aggregation. Avoid without prescriber oversight. |
Dan shen (Salvia miltiorrhiza) | Anticoagulant + antiplatelet + CYP3A4 | Major | Well-documented anticoagulant/antiplatelet properties. Serious DOAC risk. |
Schisandra | CYP3A4 inhibition | Major | Increases levels of CYP3A4 substrates. |
Nattokinase | Direct fibrinolytic | Major | Directly breaks down fibrin. Serious bleeding risk with any anticoagulant. |
Bromelain (high-dose) | Antiplatelet + fibrinolytic | Moderate–Major | High supplemental doses only. Dietary pineapple not a concern. |
MSK About Herbs — Oncology-Relevant Interactions
Memorial Sloan Kettering's Integrative Medicine Service maintains the About Herbs database (aboutherbs.com), providing evidence-based interaction summaries for over 300 dietary supplements. Summary from MSK's published data and Lam et al., J Pharm Pract 2019 (PMC6777855).
Herb / Supplement | MSK Interaction Finding | Tier |
|---|
Turmeric / Curcumin | In vitro platelet inhibition; CYP2C9 inhibition (IC50 4.3 μM). Oral intake unlikely to reach CYP3A4-inhibiting concentrations. | RED |
Reishi mushroom | MSK: "Reishi can increase the risk of bleeding" with anticoagulants. CYP2E1, CYP1A2, CYP3A inhibition in vitro. | RED |
Chaga mushroom | Platelet aggregation inhibition in murine model. High oxalate content; toxic in renal disease. | YELLOW |
Boswellia (frankincense) | Alcohol extract inhibits platelet aggregation. Water extract did not. | YELLOW |
Ashwagandha | Per MSK: does NOT interact with CYP3A4 or CYP2D6 in human liver microsomes. | GREEN |
Green tea (EGCG) | Oral EGCG (even 3 g) unlikely to significantly inhibit CYP2D6. High fasting doses → liver toxicity. | GREEN/YELLOW |
Dandelion | CYP1A2 and CYP3A4 inhibition (preclinical). Estrogenic activity. | YELLOW |
AHCC (mushroom extract) | Induces CYP2D6. CYP2D6 is not a major apixaban pathway. Low concern for Eliquis. | GREEN |
Graviola (soursop) | Additive hypoglycemia and hypotension (mouse). No direct anticoagulant interaction. | YELLOW |
Coriolus versicolor (turkey tail) | Low interaction risk. May interact with immunosuppressants. | GREEN |
Key MSK principle: Most herb-drug interaction data come from preclinical (in vitro and animal) studies. Clinical relevance in humans is often unknown. Culinary herbs in small quantities for flavoring are generally safe — concentrated supplement forms carry the interaction risk.
Practical Guidance
Before starting any supplement on apixaban:
- Have your pharmacist check the actual supplement label against your full medication list. Combination products often contain hidden herbal blends.
- Start one supplement at a time so any adverse effects can be attributed to the right product.
- Watch for signs of increased bleeding: unusual bruising, nosebleeds, bleeding gums, blood in urine or stool, heavier menstrual periods.
- Never stop or reduce apixaban to accommodate a supplement.
Seek urgent care for:
- Black or tarry stools
- Vomiting blood or material that looks like coffee grounds
- Bleeding that will not stop with pressure
- Severe new headache with weakness, dizziness, or vision changes
- Unexpected heavy bruising without trauma
Label-reading tips:
- Look for "proprietary blend" on the Supplement Facts panel — this often hides exact amounts of herbal ingredients.
- Check for turmeric/curcumin, ginkgo, garlic extract, ginger extract, or vitamin E anywhere in ingredients.
- "Natural" does not mean "no interaction." Many RED-list supplements are plant-derived.
- If the label says "supports healthy circulation" or "promotes blood flow," assume antiplatelet activity and check before combining.
Sources
- Drugs.com — Eliquis Drug Interactions (drugs.com/drug-interactions/apixaban,eliquis.html)
- HelloPharmacist — Supplement-Drug Interaction Checker (hellopharmacist.com)
- GoodRx — Eliquis Interactions (goodrx.com/eliquis/interactions)
- MedFinder — Apixaban Drug Interactions (medfinder.com)
- ISMP — Eliquis Patient Safety Guide
- MSK About Herbs Database (mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs)
- Lam et al. — Top 10 Dietary Supplements Among Cancer Patients, J Pharm Pract 2019 (PMC6777855)
- MSK Reishi Mushroom Monograph (mskcc.org/cancer-care/integrative-medicine/herbs/reishi-mushroom)
As of November 2026. Interaction data evolves; verify current status with your pharmacist before making changes.